Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis

Shiao‐Ya Hong(National Yang Ming Chiao Tung University), Kun‐Lun Huang(Tri-Service General Hospital)
Cell Death and Disease
June 8, 2023
Cited by 37


Related Papers